Today at Berkeley Lab

Study Pinpoints Most Active Areas of Reactions on Nanoscale Particles

Defects and jagged surfaces at the edges of nanosized platinum and gold particles are key hot spots for chemical reactivity, researchers confirmed using a unique infrared probe at Berkeley Lab. The findings could help scientists customize the structural properties of catalysts to make them more effective in fostering chemical reactions. More>

You can leave a comment. View the Comment Policy.

Berkeley Innovators Named Fellows of National Academy of Inventors

The Lab’s Paul Alivisatos, Amy Herr, and Enrique Iglesia were among 175 inductees. Election is a “distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society.” More>

You can leave a comment. View the Comment Policy.

NSF Director Speaks at Dec. 5 ‘10 Big Ideas for Future Investment’ Event

Employees are invited to attend a special “Science Leadership and Management” (SLAM) seminar featuring astrophysicist France Córdova, director of the National Science Foundation. The seminar will be held on Monday, Dec. 5, at 5:30 p.m. in 106 Stanley with pre-seminar coffee and cookies.

You can leave a comment. View the Comment Policy.

Nov. 2 Burris Cunningham Lecture Features David Dixon

The Glenn T. Seaborg Center will host a reception, Wednesday, Nov. 2, at 3:30 p.m., followed by the 4 p.m. lecture in the Building 50 Auditorium. Speaker David Dixon will discuss “Computational Studies of Actinide Hydrolysis and High Oxidation States.” Cunningham is famed for isolating a visible quantity of a synthetic chemical element. More>

You can leave a comment. View the Comment Policy.

Lab’s Abergel Receives ACS Rising Star Award for Women Scientists

The award, sponsored by the Women Chemists Committee of the American Chemical Society, was established to help promote retention of women in science. Chemical scientist Rebecca Abergel is among the 2017 recipients. Watch Abergel explain creating a pill to treat radiation exposure at a 2014 Science at the Theater event.

You can leave a comment. View the Comment Policy.

Scientists Rev Up Speed of Bionic Enzyme Reactions

Bionic enzymes got a needed boost in speed thanks to new Berkeley Lab research. By pairing a noble metal with a natural enzyme, scientists created a hybrid capable of churning out 2,550 product molecules per hour, a frequency comparable to biological counterparts. This could open up a world of beneficial molecular products not currently possible with natural enzymes. More>

You can leave a comment. View the Comment Policy.

Chemical Sciences Division Hosts Inaugural Postdoc Retreat

The agenda for the July 21 event included research presentations, discussions on diversity, inclusion, and implicit bias, a presentation by the Berkeley Lab Postdoc Association, a Chemical Sciences “Alumni Highlight” showcasing opportunities after Lab postdoctoral work, and a career development workshop. More>

You can leave a comment. View the Comment Policy.

Adding Cobalt Keeps Technetium From Leaving During Waste Processing

When Technetium is heated for long-term storage, this radionuclide is able to migrate, making it difficult to meet DOE retention targets. A team including the Lab’s Wayne Lukens, and researchers from Pacific Northwest National Laboratory and the DOE’s Office of River Protection, using NERSC, devised a way to retain more technetium. They added cobalt. More>

You can leave a comment. View the Comment Policy.

On the Path Toward Bionic Enzymes

Berkeley Lab chemists have successfully married chemistry and biology to create reactions never before possible. They did this by replacing the iron normally found in the muscle protein myoglobin with iridium, a noble metal not known to be used by living systems. More>

You can leave a comment. View the Comment Policy.

Chemical ‘Sponges’ Soak Up Toxic Cancer-fighting Drugs After Targeting Tumors

Researchers are creating materials for a cancer treatment system that can limit the side effects of chemotherapy drugs by quickly removing them from the body after use. The device can be inserted via a tiny tube into a vein, then soaks up most of these drugs like a sponge. More>

You can leave a comment. View the Comment Policy.